Yale psychiatrist fails in attempt to get her job back

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
288
Yale psychiatrist fails in attempt to get her job back after calling Trump mentally ill

09439c18-6cba-4f6c-9f93-dafe5245f7c2-860x475.jpg

U.S. District Judge Sarah Merriam dismissed Dr. Bandy Lee’s wrongful termination lawsuit against Yale University.

The lawsuit accused Yale of violating Lee’s free speech and professional obligations when she was not reappointed to her role with the school. She claims she was fired over her public statements criticizing then-President Donald Trump and his inner circle. Lee blames her termination on a letter sent to Yale by Trump’s friend Alan Dershowitz.

Dr. Lee was not considered a staff member or employee of Yale University.

She was a voluntary, unpaid staff member. She sued Yale last March over breach of contract and lack of good faith, involving her academic freedom. She claimed she was threatened to be fired by her department chair after Alan Dershowitz wrote a letter to Yale in 2020.

Dershowitz is a Trump lawyer and friend and a Yale law school graduate.


Lee gained national recognition in 2017 when she held a conference at Yale that focused on Trump’s mental health. She then wrote a book speculating about Trump’s mental health and got other professionals involved.

It was titled “The Dangerous Case of Donald Trump: 27 Psychiatrists and Mental Health Experts Assess a President.”

She went all in on the subject. She briefed dozens of members of the House and Senate, the media was thrilled to have Lee on to talk about her professional opinions about Trump even though she had never even met the man, House Democrats planned a town hall on Trump’s mental health, and talk of using the 25th Amendment became an obsession in D.C.

Dr. Lee was reprimanded by the American Psychiatric Association (APA) for her use of “armchair psychiatry.”

It was clear at the time to everyone not deeply infected with Trump Derangement Syndrome that Lee was way out of bounds for what she was doing. She was diagnosing someone who was not a patient and whom she had never even met.

Yet, Trump’s mental health became a topic of discussion because Democrats and other Trump deranged people saw it as a way to get him out of the White House.

Lee didn’t just leave it at Trump, though, she included his inner circle among the mentally ill. She said it was Trump’s fault, of course, but it turns out that people don’t like to be called mentally ill on national television by a psychiatrist they have never met. So, Dershowitz wrote to his alma mater and complained.

In her complaint, Lee restated a characterization she made of Dershowitz in which she alleged “he has wholly taken on Trump’s symptoms by contagion” and referred to “shared psychosis.”

Dershowitz said at the time that Lee “attributed to me a lot more power than I think I actually have. All I did was alert the Yale authorities to her unprofessional conduct. The facts are the facts,” and said he had never met Lee.

He said he called for Yale to investigate Lee’s conduct. “I think that Yale was right to look into it and then its their decision,” he said at the time.

Yale let her go after 17 years. The department cited her lack of a formal teaching role, though she had been in her voluntary, unpaid position for 17 years. She sought reinstatement, damages from lost income, emotional distress, and harm to her reputation in her lawsuit. She justified her behavior by saying it was her “duty to warn” people about the “contagion” of Trump’s mental state. Yale questioned her judgment and ability to teach after making the statements about Trump and his inner circle.

Lee cites the Goldwater Rule in her defense, claiming it was distorted in her case. The Goldwater Rule “is a statement of ethics first issued by the American Psychiatric Association in 1973 restraining psychiatrists from speculating about the mental state of public figures. The rule enjoins psychiatrists from professionally diagnosing someone they have not personally evaluated,” according to Psychology Today.

“After Yale’s first motion to dismiss was denied, the presiding judge was promptly replaced without cause or explanation,” she wrote. “Then, the case was stalled for more than eight months. Also, the argument is much like the distortion of the Goldwater rule itself — full of misleading plays on impression instead of investigating the truth.”

She insisted the Goldwater Rule doesn’t apply to her because she isn’t a member of the APA. Her legal team said Trump’s presidency required psychiatrists to sound alarms.

Lee insisted that didn’t apply to her because she isn’t a member of the organization and the rule is meant to prevent members from issuing grave public warnings.

“Trump’s presidency represented an emergency which not only allowed, but required, psychiatrists in the United States to sound the alarms,” Lee’s legal team said of her “professional responsibility to protect society.”

“Trump’s mental health was affecting the mental health” of everyone in the US, “placing the country at grave risk” and “undermining democracy itself,” according to the lawsuit of Lee, who also edited the 2017 book “The Dangerous Case of Donald Trump: 27 Psychiatrists and Mental Health Experts Assess a President.”

The judge didn’t agree with Lee’s complaints after Yale let her go.

U.S. District Judge Sarah Merriam rejected Lee’s breach of contract claims Tuesday because, she wrote, there wasn’t any implied contract that Yale would automatically reappoint Lee to the faculty position, regardless of Lee’s qualifications.

“These three alleged generic expressions of ‘approval and appreciation’ or commendation are insufficient to even suggest a promise of continued appointment, much less support a contractual commitment,” Merriam wrote, referring to positive statements Lee claimed she received from Yale administrators.

Merriam wrote in her opinion that Lee’s “vague assertion” that the faculty handbook guarantees academic freedom was “plainly insufficient to show that defendant undertook a contractual commitment.”

Lee also sued the university under Connecticut’s employment law under a free speech statute, which the court also rejected because Lee wasn’t considered an employee of the university as an unpaid volunteer, according to legal interpretation.

“The question is not whether plaintiff was hired as an independent contractor or an employee,” Merriam wrote. “Rather, the question is whether plaintiff was hired at all.”

Even though Lee was not paid, she claimed she had access to employee-only resources on campus, but the court ruled that they were inefficient to establish an employer-employee relationship.

She was sent a letter from her department head after Dershowitz wrote his letter that warned her of looking self-serving in relation to her personal political belief and personal aspirations. He hit the nail on the head. Lee admitted that though she was unpaid at Yale, she used the gig as a way to earn “potentially tens of thousand s of dollars in perks and exposure” that allowed her to be a global consultant. It’s always about the money.

Funny how she’s not rushing on cable news channels now to talk about our current dazed and confused president. Isn’t she concerned that Biden appears to be in the early stages of dementia? Probably not because he’s a Democrat, right?

Where are all the other Democrats who talked so much about the 25th Amendment during Trump’s administration? Oh, never mind.

https://hotair.com/karen-townsend/2022/09/03/...ll-n494317
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 238

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 522

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 271

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 202

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 104

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian Stocks Surge: Understanding Market Dynamics and Trends

Updated Category News Views 178

Canadian Stocks See Notable Gains The Canadian stock market has shown encouraging signs of growth lately, with various sectors playing a part in this upward movement. The S&P/TSX Composite Index achieved a remarkable increase of 0.57%, marking a significant point in its trading history. Key Sectors Driving Market Growth The rise in stock prices can largely be credited to...

Continue Reading
Bookmark Medical Enters Michigan Via Village Medical Buy

Updated Category News Views 38

Stepping into Michigan It might not be a Wall Street headliner, but Bookmark Medical's move into Michigan sure says a lot about their growth ambitions. On August 3, 2026, the Nashville-based healthcare group wrapped up acquiring Village Medical Michigan. This is Bookmark's maiden voyage into the Great Lake State, where it's taken over the reins of seven primary care...

Continue Reading
Astrotech Corporation Reports Impressive Year-End Results

Updated Category News Views 134

Astrotech Corporation Reports Strong Fiscal Performance Recently, Astrotech Corporation (NASDAQ: ASTC) announced its financial results for the fiscal year that ended on June 30. The report highlights notable advancements from its subsidiary, 1st Detect, and how these developments are contributing to overall revenue and growth potential. Key Financial Highlights The...

Continue Reading
Neptune Flood Research Highlights Path to Private Insurance Transition

Updated Category News Views 165

Neptune Flood Research Report Offers Insights on NFIP Transition Recent research indicates that private flood insurers may be capable of taking on 95% of policies from the NFIP, helping to mitigate federal financial exposure. Neptune Flood Research Group has published a comprehensive report analyzing the U.S. flood insurance market. The study emphasizes the challenges...

Continue Reading
Valerio Therapeutics Shifts Focus to Early-Stage Drug Development

Updated Category News Views 131

Valerio Therapeutics Announces Strategic Refocus Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) has made a pivotal announcement regarding its strategic business direction. The company has decided to halt all clinical trials, including the ongoing VIO-01 trial. This decision comes in response to significant financing challenges impacting the organization. While...

Continue Reading